These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3076415)

  • 21. Peptide interactions with class I and II MHC encoded molecules.
    Pecht I
    Isr J Med Sci; 1994 Mar; 30(3):28-31. PubMed ID: 7514162
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation of class I antigen expression with immunogenicity.
    Almond PS; Baumgardner GL; Chen S; Cunningham TR; Payne WD; Matas AJ
    Curr Surg; 1990; 47(4):262-4. PubMed ID: 2397644
    [No Abstract]   [Full Text] [Related]  

  • 23. CD4 and CD8 recognition of class II and class I molecules of the major histocompatibility complex.
    Fleury SG; Croteau G; Sékaly RP
    Semin Immunol; 1991 May; 3(3):177-85. PubMed ID: 1909595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dichotomy of peptide presentation by class I and class II MHC proteins.
    Urban RG; Chicz RM; Vignali DA; Strominger JL
    Chem Immunol; 1993; 57():197-234. PubMed ID: 8260088
    [No Abstract]   [Full Text] [Related]  

  • 25. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8.
    König R; Huang LY; Germain RN
    Nature; 1992 Apr; 356(6372):796-8. PubMed ID: 1574118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of MHC class I and II antigen expression in immune surveillance against tumors. II. Experimental systems.
    Semin Cancer Biol; 1991 Oct; 2(5):273-354. PubMed ID: 1773043
    [No Abstract]   [Full Text] [Related]  

  • 27. What a rheumatologist needs to know about T cell receptor structure and function.
    Fathman CG
    J Rheumatol Suppl; 1992 Jan; 32():12-5; discussion 15-7. PubMed ID: 1613729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell clones and monoclonal antibodies: immunologic probes of major histocompatibility complex class I molecules.
    Bluestone JA; Potter T
    Chem Immunol; 1989; 46():23-48. PubMed ID: 2514705
    [No Abstract]   [Full Text] [Related]  

  • 29. Thymic development in human CD4 transgenic mice. Positive selection occurs after commitment to the CD8 lineage.
    Paterson RK; Burkly LC; Kurahara DK; Dunlap A; Flavell RA; Finkel TH
    J Immunol; 1994 Oct; 153(8):3491-503. PubMed ID: 7930572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between peptides and major histocompatibility complex molecules during antigen processing and presentation.
    Forquet F; Danilczyk U; Lang Y; Delovitch TL
    Chem Immunol; 1993; 57():63-87. PubMed ID: 8260090
    [No Abstract]   [Full Text] [Related]  

  • 31. Presentation of antigen and MHC-restricted unresponsiveness.
    Ríhová B
    Folia Biol (Praha); 1995; 41(3-4):140-62. PubMed ID: 7589711
    [No Abstract]   [Full Text] [Related]  

  • 32. Dendritic cells: open for presentation business.
    Saveanu L; van Endert P
    Nat Immunol; 2005 Jan; 6(1):7-8. PubMed ID: 15611772
    [No Abstract]   [Full Text] [Related]  

  • 33. Intracellular traffic and antigen processing.
    Long EO
    Immunol Today; 1989 Jul; 10(7):232-4. PubMed ID: 2679635
    [No Abstract]   [Full Text] [Related]  

  • 34. Structure, specificity and CDR mobility of a class II restricted single-chain T-cell receptor.
    Hare BJ; Wyss DF; Osburne MS; Kern PS; Reinherz EL; Wagner G
    Nat Struct Biol; 1999 Jun; 6(6):574-81. PubMed ID: 10360364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of recovery from ischemic injury on class I and class II MHC antigen expression.
    Shackleton CR; Ettinger SL; McLoughlin MG; Scudamore CH; Miller RR; Keown PA
    Transplantation; 1990 Mar; 49(3):641-4. PubMed ID: 2180154
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of major histocompatibility complex class I, class II and TLA genes on tumor rejection.
    Ostrand-Rosenberg S; Garcia EP; Roby CA; Clements VK
    Semin Cancer Biol; 1991 Oct; 2(5):311-9. PubMed ID: 1773047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of gamma delta receptor bearing T cells.
    Matis LA; Bluestone JA
    Semin Immunol; 1991 Mar; 3(2):75-80. PubMed ID: 1716171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of class I+, class II- hepatocytes.
    Almond PS; Bumgardner GL; Chen S; Platt J; Payne WD; Matas AJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):108-9. PubMed ID: 1899298
    [No Abstract]   [Full Text] [Related]  

  • 39. The cell biology of antigen presentation.
    Hudson AW; Ploegh HL
    Exp Cell Res; 2002 Jan; 272(1):1-7. PubMed ID: 11740859
    [No Abstract]   [Full Text] [Related]  

  • 40. Memory T cells generated in vitro to class I+, II- hepatocytes.
    Bumgardner GL; Almond PS; Chen S; Matas AJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):104-5. PubMed ID: 1990489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.